Screening for Prostate Cancer with Prostate-specific Antigen: The Journey Continues

被引:3
|
作者
Avagimyan, Ashot [1 ]
Gvianishvili, Tamuna [2 ]
Gogiashvili, Liana [3 ]
Kakturskiy, Lev [4 ]
Sarrafzadegan, Nizal [5 ]
Aznauryan, Artashes [6 ]
机构
[1] Yerevan State Med Univ, Anat Pathol Dept, Yerevan, Armenia
[2] Ivane Javakhishvili Tbilisi State Univ, Alexandre Natishvili Inst Morphol, Dept Clin & Expt Pathol, Tbilisi, Georgia
[3] Ivane Javakhishvili Tbilisi State Univ, Alexandre Natishvili Inst Morphol, Dept Clin & Expt Pathol, Tbilisi, Georgia
[4] Russian Soc Pathol, FSBI Res Inst Human Morphol, Moscow, Russia
[5] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Esfahan, Iran
[6] Yerevan State Med Univ, Histol Dept, Yerevan, Armenia
关键词
TRASTUZUMAB-INDUCED CARDIOTOXICITY; SUBCLINICAL HYPOTHYROIDISM; RISK-FACTOR; ANTHRACYCLINE; DOXORUBICIN; DISEASE; PACLITAXEL; PREDICTION; STRESS; HEART;
D O I
10.1016/j.cpcardiol.2021.101051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the population, as well as the economic burden of the health care system. Currently, CVDs account for more than 17.6 million deaths a year and are projected to exceed 23.6 million by 2030. Unstable atheroma, and its rupture, underlies the pathology of most cardiovascular complications, particularly acute coronary syndrome, mortality from which, compared with other CV events, remains the leading one. Despite numerous efforts by WHO, national health systems, and medical authorities, the incidence and mortality from cardiovascular events remain critically high. Thus, the search for new risk factors for the development of CV pathology looks very relevant. Our working group decided to amalgamate our research data, which reflects the study of modern risk factors from the Armenian, Russian,
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Prostate-specific antigen and prostate cancer
    Rosalki, SB
    Rutherford, FJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, 54 (09) : 611 - 613
  • [32] On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
    Bangma, Chris H.
    van Schaik, Ron H.
    Blijenberg, Bert G.
    Roobol, Monique J.
    Lilja, Hans
    Stenman, Ulf-Hakan
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (17) : 3109 - 3119
  • [33] PROSTATE-SPECIFIC ANTIGEN SCREENING AND IMPLICATIONS FOR TREATMENT OPTIONS IN PROSTATE CANCER
    Heinzer, H.
    Haese, Al.
    Schlomm, Th.
    Steuber, Th.
    Michl, U.
    Salomon, G.
    Thederan, I.
    Huland, H.
    Graefen, M.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979
  • [34] Prostate-Specific Antigen Screening and Recent Increases in Advanced Prostate Cancer
    Nyame, Yaw A.
    Gulati, Roman
    Tsodikov, Alex
    Gore, John L.
    Etzioni, Ruth
    JNCI CANCER SPECTRUM, 2021, 5 (01)
  • [35] ECONOMIC EVALUATION OF PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER IN CHINA
    Qin, X.
    Gu, C.
    Huang, Y.
    Gu, W.
    Dai, B.
    Zhang, H.
    Zhu, Y.
    Liu, T.
    Qu, S.
    Liu, Y.
    Yang, H.
    Ye, D.
    VALUE IN HEALTH, 2021, 24 : S235 - S235
  • [36] Identification of clinically significant prostate cancer by prostate-specific antigen screening
    Smith, RP
    Malkowicz, SB
    Whittington, R
    VanArsdalen, K
    Tochner, Z
    Wein, A
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (11) : 1227 - 1230
  • [37] POPULATION BASED ASSESSMENT OF PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER
    Williams, Stephen
    Carter, Stacey
    Eggener, Scott
    Prasad, Sandip
    Chamie, Karim
    Trinh, Quoc-Dien
    Sun, Maxine
    Nguyen, Paul
    Lipsitz, Stuart
    Hu, Jim
    JOURNAL OF UROLOGY, 2014, 191 (04): : E708 - E709
  • [38] Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening
    Brooks, James D.
    CANCER, 2013, 119 (22) : 3906 - 3909
  • [40] Analytical issues on prostate-specific antigen in relation to prostate cancer screening
    Blijenberg, BG
    Roobol, M
    Schröder, FH
    CLINICAL BIOCHEMISTRY, 1998, 31 (08) : 633 - 639